SharesGrow.com Intrinsic Value of S&P & Nasdaq Contact Us

हिन्दी

← Back to all stocks

Sonova Holding AG SONVY OTC

Other OTC • Healthcare • Medical - Devices • CH • USD

SharesGrow Score

SharesGrow Intrinsic Value

Negative cash flow

Sonova Holding AG (SONVY) is a Medical - Devices company in the Healthcare sector, currently trading at $47.46. It has a SharesGrow Score of 58/100, indicating a above average investment profile with 3 out of 7 criteria passed.

Financials: revenue is $3.9B, +4.9%/yr average growth. Net income is $541M, growing at -5.8%/yr. Net profit margin is 14% (healthy). Gross margin is 72% (+0 pp trend).

Balance sheet: total debt is $1.8B against $2.7B equity (Debt-to-Equity (D/E) ratio 0.66, moderate). Current ratio is 1.27 (adequate). Debt-to-assets is 29.7%. Total assets: $5.9B.

Analyst outlook: 0 / 1 analysts rate SONVY as buy (0%) — mixed sentiment.

SharesGrow 7-Criteria breakdown: Value 60/100 (Pass), Growth 30/100 (Fail), Past 100/100 (Pass), Health 67/100 (Partial), Moat 76/100 (Pass), Future 20/100 (Fail), Income 55/100 (Partial).

SONVY SharesGrow Score Overview

58/100

SharesGrow Score

Above average fundamentals

View full scorecard →

VALUE 60/100

Valuation — P/E, PEG, Forward PEG

GROWTH 30/100

Financials — average growth

PAST 100/100

strong — trend

HEALTH 67/100

Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is

MOAT 76/100

Gross margin is + market cap

FUTURE 20/100

Analyst outlook — as buy

INCOME 55/100

Net profit margin is

Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — SONVY

SONVY trades at a trailing Price-to-Earnings (P/E) of N/A (S&P 500 average ~25). Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.

View details →

SONVY: +4.9%/yr revenue is, -5.8%/yr Net income is average growth. mixed. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.

View details →

SONVY: 4 / 4 years profitable. strong — 100%. Score = 4 / 4 × 100. ≥ 80 = Pass.

View details →

Balance sheet SONVY: Debt-to-Equity (D/E) ratio 0.66 (moderate), Current ratio is 1.27 (adequate). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.

View details →

SONVY: Gross margin is 72% (+0 pp trend), $14B market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 76/100. ≥ 70 = Pass.

View details →

Analyst outlook: 0 / 1 analysts rate SONVY as buy (0%). Score: 60% buy consensus + 40% upside. ≥ 60 = Pass.

View details →

SONVY: Net profit margin is 14%. thin (5-15%). Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.

View details →

Stock Chart & Stats

Market Data

52-Week Range42.26-68.76

Volume14.69K

Avg Volume (30D)43.19K

Market Cap$14.15B

Beta (1Y)1.14

Dividend Yield$1.0770

Share Statistics

EPS (TTM)1.81

Shares Outstanding$298.15M

IPO Date2011-04-06

Employees18,335

CEOEric Bernard

Financial Highlights & Ratios

Revenue (TTM)$3.87B

Gross Profit$2.78B

EBITDA$927M

Net Income$540.5M

Operating Income$691.9M

Total Cash$687.1M

Total Debt$1.76B

Net Debt$1.07B

Total Assets$5.92B

Price / Earnings (P/E)26.2

Price / Sales (P/S)3.66

Analyst Forecast

Rating ConsensusSell

Analysts Covering1

Buy 0% Hold 0% Sell 100%

Company Info

CountryCH

ExchangeOther OTC

CurrencyUSD

ISINUS83569C1027

Price Chart

SONVY

Sonova Holding AG ↗ · Other OTC

Healthcare • Medical - Devices

42.26 52WK RANGE 68.76

People Also View

Smith & Nephew plc

GN Store Nord A/S

GN Store Nord A/S

CONMED Corporation

Contact Us

🎓

SharesGrow Academy

Learn how to calculate Intrinsic Value and find undervalued stocks.

Weekly live sessions

📧 [email protected]

📞 +65 8912 8000

Send us a message